Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 3
1949 5
1950 1
1952 2
1954 1
1962 2
1963 1
1964 1
1965 1
1966 2
1967 2
1968 1
1969 5
1970 4
1971 4
1972 5
1973 6
1975 2
1976 2
1978 4
1979 1
1981 2
1982 1
1983 5
1985 1
1986 3
1987 4
1988 3
1989 3
1990 1
1992 1
1993 2
1994 3
1995 1
1997 1
1998 1
2000 1
2009 1
2011 2
2012 3
2014 1
2015 4
2016 1
2017 4
2018 6
2020 6
2021 13
2022 11
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. Among authors: dempsey w. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
A randomized trial of a mobile health intervention to augment cardiac rehabilitation.
Golbus JR, Gupta K, Stevens R, Jeganathan VSE, Luff E, Shi J, Dempsey W, Boyden T, Mukherjee B, Kohnstamm S, Taralunga V, Kheterpal V, Murphy S, Klasnja P, Kheterpal S, Nallamothu BK. Golbus JR, et al. Among authors: dempsey w. NPJ Digit Med. 2023 Sep 14;6(1):173. doi: 10.1038/s41746-023-00921-9. NPJ Digit Med. 2023. PMID: 37709933 Free PMC article.
Hybrid Experimental Designs for Intervention Development: What, Why, and How.
Nahum-Shani I, Dziak JJ, Walton MA, Dempsey W. Nahum-Shani I, et al. Among authors: dempsey w. Adv Methods Pract Psychol Sci. 2022 Jul-Sep;5(3):10.1177/25152459221114279. doi: 10.1177/25152459221114279. Epub 2022 Sep 7. Adv Methods Pract Psychol Sci. 2022. PMID: 36935844 Free PMC article.
144 results